Access to medicines and hepatitis C in Africa: can tiered pricing and voluntary licencing assure universal access, health equity and fairness?
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1744-8603
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Access to medicines and hepatitis C in Africa: can tiered pricing and voluntary licencing assure universal access, health equity and fairness? ; volume:13 ; number:1 ; day:13 ; month:9 ; year:2017 ; pages:1-11 ; date:12.2017
Globalization and health ; 13, Heft 1 (13.9.2017), 1-11, 12.2017
- Urheber
-
Assefa, Yibeltal
- Beteiligte Personen und Organisationen
-
Hill, Peter S.
Ulikpan, Anar
Williams, Owain D.
SpringerLink (Online service)
- DOI
-
10.1186/s12992-017-0297-6
- URN
-
urn:nbn:de:1111-201711151370
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Assefa, Yibeltal
- Hill, Peter S.
- Ulikpan, Anar
- Williams, Owain D.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Guidelines on patentability and access to medicines
Strengthening access to medicines through transparency and accountability
Medicines patents, access and innovation : the growing challenges for people in low and middle-income countries to access new medicines
How to assure access of essential RMNCH medicines by looking at policy and systems factors: an analysis of countdown to 2015 countries
How AI developers can assure algorithmic fairness
Access to subsidised medicines, cost of medicines and health outcomes: exploring general practitioners' perceptions and experiences
Can NGOs regulate medicines markets? Social enterprise in wholesaling, and access to essential medicines
Local production of pharmaceuticals in Africa and access to essential medicines: 'urban bias’ in access to imported medicines in Tanzania and its policy implications
Competition law and access to medicines: Lessons from Brazilian regulation and practice
Intellectual property, public health and access to medicines in international organizations
Access to COVID-19 Vaccines and Medicines - a Global Public Good
Access to innovative oncology medicines in Europe
Guidelines on patentability and access to medicines
Strengthening access to medicines through transparency and accountability
Medicines patents, access and innovation : the growing challenges for people in low and middle-income countries to access new medicines
How to assure access of essential RMNCH medicines by looking at policy and systems factors: an analysis of countdown to 2015 countries
How AI developers can assure algorithmic fairness
Access to subsidised medicines, cost of medicines and health outcomes: exploring general practitioners' perceptions and experiences
Can NGOs regulate medicines markets? Social enterprise in wholesaling, and access to essential medicines
Local production of pharmaceuticals in Africa and access to essential medicines: 'urban bias’ in access to imported medicines in Tanzania and its policy implications
Competition law and access to medicines: Lessons from Brazilian regulation and practice
Intellectual property, public health and access to medicines in international organizations
Access to COVID-19 Vaccines and Medicines - a Global Public Good
Access to innovative oncology medicines in Europe
Guidelines on patentability and access to medicines
Strengthening access to medicines through transparency and accountability
Medicines patents, access and innovation : the growing challenges for people in low and middle-income countries to access new medicines
How to assure access of essential RMNCH medicines by looking at policy and systems factors: an analysis of countdown to 2015 countries
How AI developers can assure algorithmic fairness
Access to subsidised medicines, cost of medicines and health outcomes: exploring general practitioners' perceptions and experiences
Can NGOs regulate medicines markets? Social enterprise in wholesaling, and access to essential medicines
Local production of pharmaceuticals in Africa and access to essential medicines: 'urban bias’ in access to imported medicines in Tanzania and its policy implications
Competition law and access to medicines: Lessons from Brazilian regulation and practice
Intellectual property, public health and access to medicines in international organizations
Access to COVID-19 Vaccines and Medicines - a Global Public Good